221 related articles for article (PubMed ID: 35531668)
1. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
2. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
3. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
[TBL] [Abstract][Full Text] [Related]
4. Does genetic risk modify the effect of skin screening on melanoma detection rates?
Pandeya N; Dusingize JC; Olsen CM; MacGregor S; Neale RE; Law MH; Whiteman DC
Br J Dermatol; 2023 Dec; 190(1):37-44. PubMed ID: 37681503
[TBL] [Abstract][Full Text] [Related]
5. Incidence of in Situ vs Invasive Melanoma: Testing the "Obligate Precursor" Hypothesis.
Olsen CM; Pandeya N; Rosenberg PS; Whiteman DC
J Natl Cancer Inst; 2022 Oct; 114(10):1364-1370. PubMed ID: 36042554
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population.
Olsen CM; Pandeya N; Dusingize JC; Neale RE; MacGregor S; Law MH; Whiteman DC;
JAMA Dermatol; 2023 Jan; 159(1):37-46. PubMed ID: 36416830
[TBL] [Abstract][Full Text] [Related]
7. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.
Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E
JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131
[TBL] [Abstract][Full Text] [Related]
8. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
Hübner J; Waldmann A; Geller AC; Weinstock MA; Eisemann N; Noftz M; Bertram S; Nolte S; Volkmer B; Greinert R; Breitbart E; Katalinic A
Br J Cancer; 2017 Jan; 116(2):253-259. PubMed ID: 27898656
[TBL] [Abstract][Full Text] [Related]
9. Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method.
Adamson AS; Naik G; Jones MA; Bell KJ
BMJ Evid Based Med; 2024 May; 29(3):156-161. PubMed ID: 38242569
[TBL] [Abstract][Full Text] [Related]
10. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
11. A 10-Year Follow-Up Study of Subjects Recruited in a Health Campaign for the Early Diagnosis of Cutaneous Melanoma: Suggestions for the Screening Timetable.
Cristofolini M; Boi S; Cattoni D; Sicher MC; Decarli A; Micciolo R
Dermatology; 2015; 231(4):345-52. PubMed ID: 26278413
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and initial management of melanoma in Australia: findings from the prospective, population-based QSkin study.
Pandeya N; Olsen CM; Shalit MM; Dusingize JC; Neale RE; Whiteman DC
Med J Aust; 2023 May; 218(9):402-407. PubMed ID: 37041657
[TBL] [Abstract][Full Text] [Related]
13. A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.
Ferris LK; Saul MI; Lin Y; Ding F; Weinstock MA; Geller AC; Yuan JM; Neuren E; Maddukuri S; Solano FX; Kirkwood JM
JAMA Oncol; 2017 Aug; 3(8):1112-1115. PubMed ID: 28241191
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
[TBL] [Abstract][Full Text] [Related]
15. Clinical whole-body skin examination reduces the incidence of thick melanomas.
Aitken JF; Elwood M; Baade PD; Youl P; English D
Int J Cancer; 2010 Jan; 126(2):450-8. PubMed ID: 19609948
[TBL] [Abstract][Full Text] [Related]
16. Association Between Melanoma Detected During Routine Skin Checks and Mortality.
Watts CG; McLoughlin K; Goumas C; van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE
JAMA Dermatol; 2021 Dec; 157(12):1425-1436. PubMed ID: 34730781
[TBL] [Abstract][Full Text] [Related]
17. Overdiagnosis in malignant melanoma: a scoping review.
Bjørch MF; Gram EG; Brodersen JB
BMJ Evid Based Med; 2024 Jan; 29(1):17-28. PubMed ID: 37793786
[TBL] [Abstract][Full Text] [Related]
18. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
Moloney FJ; Guitera P; Coates E; Haass NK; Ho K; Khoury R; O'Connell RL; Raudonikis L; Schmid H; Mann GJ; Menzies SW
JAMA Dermatol; 2014 Aug; 150(8):819-27. PubMed ID: 24964862
[TBL] [Abstract][Full Text] [Related]
19. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
